Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1078 clinical trials
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time 9 months at the time of study entry.

choline
immunological adjuvant
adenocarcinoma
serum testosterone
luteinizing hormone-releasing hormone agonist
Georgetown University Medical Center
 (7.8 away) Contact site
  • 496 views
  • 03 Jun, 2019
  • +67 other locations
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole Based on Prior Endocrine Therapy in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Study assessing the efficacy and safety of alpelisib plus fulvestrant or letrozole, based on prior endocrine therapy, in patients with PIK3CA mutation with advanced breast cancer who have progressed on or after prior treatments

PIK3CA
immunostimulant
hormone therapy
endocrine therapy
cancer treatment
Holy Cross Hospital Pharmacy
 (6.2 away) Contact site
  • 506 views
  • 19 Aug, 2020
  • +118 other locations
The iCat2 GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

This research study is evaluating the use of specialized testing of solid tumors including sequencing. The process of performing these specialized tests is called tumor profiling. The tumor profiling may result in identifying changes in genes of the tumor that indicate that a particular therapy may have activity. This is …

Children's National Medical Center
 (5.4 away) Contact site
  • 16 views
  • 23 Dec, 2019
  • +8 other locations
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

This is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with Lennox-Gastaut syndrome (LGS).

Childrens National Medical Center
 (5.4 away) Contact site
  • 112 views
  • 24 Sep, 2020
  • +98 other locations
Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

This is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven patient cohorts for up to 603 previously treated and treatment-nave NSCLC patients. Cohorts 3 and 4 were added with Amendment 1 and three additional cohorts were added with Amendment 2 (Cohorts …

HER2
stage iv non-small cell lung cancer
osimertinib
EGFR
Georgetown University Medical Center
 (7.9 away) Contact site
  • 320 views
  • 20 Sep, 2020
  • +67 other locations
Digital Dysmorphology Project

In this study, the investigators propose a novel method to detect Down syndrome using photography for facial dysmorphology, a tool called computer-aided diagnosis (CAD). After validating the method, this technology will be expanded to perform similar functions to assist in the detection of other dysmorphic syndromes. By using photography and …

Children's National
 (5.4 away) Contact site
  • 13 views
  • 08 Nov, 2020
  • 1 location
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).

Children's National Medical Center
 (5.4 away) Contact site
  • 46 views
  • 08 Nov, 2020
  • +8 other locations
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before. Their cancer: cannot be removed by an operation has spread to other parts of the body

HER2
trastuzumab
immunostimulant
her2/neu-positive breast cancer
adjuvant therapy
Washington Cancer Institute
 (5.4 away) Contact site
  • 132 views
  • 07 Oct, 2020
  • +69 other locations
PRISM Study-Pruritus Relief Through Itch Scratch Modulation

To investigate the anti-pruritic efficacy and safety of Nalbuphine ER (NAL ER) tablets in Prurigo Nodularis. Subjects will be randomized to NAL ER (or matching placebo) with the primary endpoint evaluation at Week 14. During the open label extension, subjects who received NAL ER will continue on NAL ER and …

nalbuphine
Study Site 128
 (7.0 away) Contact site
  • 661 views
  • 01 Oct, 2020
  • +75 other locations
Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

The overall aim of the study is to evaluate the efficacy, safety, and tolerability of Nefecon 16 mg per day in the treatment of patients with primary IgAN (Immunoglobulin A nephropathy) at risk of progressing to end-stage renal disease (ESRD), despite maximum tolerated treatment with renin-angiotensin system (RAS) blockade using …

Washington Nephrology Associates-Washington DC, 730 24th Street NW
 (7.1 away) Contact site
  • 735 views
  • 25 Oct, 2020
  • +153 other locations